Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vitale Cristiana, Berthelot Emmanuelle, Coats Andrew J S, Loreena Hill, Albert Nancy M, Tkaczyszyn Michal, Adamopoulos Stamatis, Anderson Lisa, Anker Markus S, Anker Stefan D, Bell Derek, Ben-Gal Tuvia, Bistola Vasiliki, Bozkurt Biykem, Brooks Poppy, Camafort Miguel, Carrero Juan Jesus, Chioncel Ovidiu, Choi Dong-Ju, Chung Wook-Jin, Doehner Wolfram, Fernández-Bergés Daniel, Ferrari Roberto, Fiuzat Mona, Gomez-Mesa Juan Esteban, Gustafsson Finn, Jankowska Ewa, Kang Seok-Min, Kinugawa Koichiro, Khunti Kamlesh, Hobbs F D Richard, Lee Christopher, Lopatin Yuri, Maddocks Matthew, Maltese Giuseppe, Marques-Sule Elena, Matsue Yuya, Miró Òscar, Moura Brenda, Piepoli Massimo, Ponikowski Piotr, Pulignano Giovanni, Rakisheva Amina, Ray Robin, Sciacqua Angela, Seferovic Petar, Sentandreu-Mañó Trinidad, Sze Shirley, Sinclair Alan, Strömberg Anna, Theou Olga, Tsutsui Hiroyuki, Uchmanowicz Izabella, Vidan Maria Teresa, Volterrani Maurizio, von Haehling Stephan, Yoo Byungsu, Zhang Jian, Zhang Yuhui, Metra Marco, Rosano Giuseppe Massimo Claudio
Аннотация
METHODS AND RESULTS: The HFFS was developed through a Delphi consensus process involving 54 international experts. This approach involved iterative rounds of questionnaires and interviews, where a panel of experts provided their opinions on specific questions prepared by the Steering Committee. The experts were invited to vote and share their views anonymously, using a 5-point Likert scale over iterative rounds. An 80% threshold was set for agreement or disagreement for each statement. Twenty-two variables from four domains (clinical, functional, psycho-cognitive and social) have been selected for inclusion in the HFFS after the third round of the Delphi process. A shorter version (S-HFFS), including 10 variables, has also been developed for daily clinical use.
CONCLUSIONS: The HFFS is a new multidimensional tool for the identification of frailty in patients with HF. It should also enables healthcare providers to identify potential 'red flags' for frailty in order to develop personalized care plans. The next step will be to validate the new score in patients with HF.